Origen de la red de primer grado Savita Bernal.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
7
| Public Company | Pharmaceuticals: Major | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Savita Bernal a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
BECTON, DICKINSON AND COMPANY | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Private Equity Investor | |
HALOZYME THERAPEUTICS, INC. | Biotechnology | Sales & Marketing | |
MODULAR MEDICAL, INC. | Medical Specialties | Corporate Officer/Principal | |
INOGEN, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Capricorn Partners NV
Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor | |
Laboratoire Precilens SA
Laboratoire Precilens SA Medical SpecialtiesHealth Technology Laboratoire Precilens SAS is a holding company engaged in the design, manufacture, and commercialization of contact lenses. It offers gas permeable and soft progressive lenses, as well as specialized corrective varieties for conditions such as presbyopia, myopia, hyperopia, and astigmatism. The company was founded in 1981 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree | |
University of Wisconsin | College/University | Doctorate Degree | |
University of Florida | College/University | Masters Business Admin | |
Moscow State University Lomonosov | College/University | Undergraduate Degree | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
ABLYNX | Biotechnology | Director/Board Member | |
NEXSTIM PLC | Medical Specialties | Director/Board Member | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
California Coast University | College/University | Masters Business Admin | |
Institut d’Administration des Entreprises | College/University | Masters Business Admin | |
GO Capital SAS
GO Capital SAS Investment ManagersFinance GO Capital SAS (GO Capital) is an independent French private equity firm founded 2003 and is headquartered in Saint-Jacques-de-la-Lande. Formerly known as Grand Ouest Gestion SAS, the firm's investors include regional and cooperative banks, Natixis and CDC PME.GO Capital is located in Rennes and focuses primarily on the northwest quarter of France, also known as Grand Ouest, which comprises the Brittany, Poitou-Charentes, Pays de la Loire and Basse Normandie regions. The firm manages the Ouest Ventures fund. | Investment Managers | Private Equity Investor | |
ACG Management SAS
ACG Management SAS Investment ManagersFinance ACG Management SAS (ACG) is the private equity subsidiary of Vivéris Holding SAS in France. The firm was formerly known as Vivéris Management SAS, established in 2000, and became ACG Management in 2014. Based in Marseille, with additional offices in Ajaccio and St. Denis de la Réunion and subsidiaries in New Caledonia and Tunisia, ACG is a multi-regional firm which provides technology venture capital, development capital, capital transmission and LBO services as well as a range of investment vehicles, including FCPIs, FIPs and FCPRs for institutional investors. | Investment Managers | Private Equity Investor | |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Genset Corp.
Genset Corp. Pharmaceuticals: MajorHealth Technology Founded in 1992, Genset Corp. is a pharmaceutical company that manufactures and markets pharmaceuticals. The company is based in San Diego, CA and is a part of Merck KGaA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DIEAU-EDAFIM SA
DIEAU-EDAFIM SA Industrial MachineryProducer Manufacturing Dieau-Edafim SA designs and manufactures water fountains and coolers connected to the domestic water system or fitted tanks. The company was founded on April 1, 1999 and is headquartered in Saint-Julien-en-Saint-Alban, France. | Industrial Machinery | Director/Board Member | |
European Private Equity & Venture Capital Association | Director/Board Member | ||
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
QIAGEN MARSEILLE | Miscellaneous Commercial Services | Director/Board Member | |
Axess Vision Technology SA
Axess Vision Technology SA Medical SpecialtiesHealth Technology Axess Vision Technology SA designs, develops, produces and commercializes surgical equipment. It offers video endoscope and electro-therapeutic products. The company was founded by Olivier Brosset, Marc Malou, Olivier Fructus and Nicolas Mathieu in February 24, 2006 and is headquartered in Saint-Pierre-des-Corps, France. | Medical Specialties | Director/Board Member | |
Kurma Biofund FCPR
Kurma Biofund FCPR Investment ManagersFinance Kurma Biofund seeks investment opportunities in life science and biotechnology companies located in Europe. The investments are done in cooperation with medical institutes and universities such as Institut Pasteur and Institut Curie. Its investment size ranges between €0.10 and €6 million. | Investment Managers | Corporate Officer/Principal | |
BIOM'UP | Medical Specialties | Director/Board Member | |
Université d'Aix-Marseille | College/University | Undergraduate Degree | |
École Supérieure de Chimie Physique Électronique | College/University | Doctorate Degree | |
iSTAR Medical SA
iSTAR Medical SA Medical SpecialtiesHealth Technology iSTAR Medical SA develops innovative ophthalmic implants. Its products include MINIject, STARflo and STAR Material. The company was founded by Michel Alvarez in 2011 and is headquartered in Wavre, Belgium. | Medical Specialties | Director/Board Member | |
Egidium Technologies SAS
Egidium Technologies SAS Packaged SoftwareTechnology Services Egidium Technologies SAS develops and markets software solutions to security and safety of critical sites. It offers a united 3-D visualization, as well as a decision-making support in real time for the site security. The company offers access control, video-protection, fire alarms, and security staff services. The company was founded by Laurent Denizot in 2009 and is headquartered Orsay, France. | Packaged Software | Director/Board Member | |
Diabetes Foundation of New Jersey | Director/Board Member | ||
MAAT PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Investor | |
Confo Therapeutics NV
Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France. | Biotechnology | Director/Board Member | |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
CELLNOVO | Medical Specialties | Director/Board Member | |
Yevdokimov MSUMD | College/University | Doctorate Degree | |
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Director/Board Member | |
Invest Europe VZW | Director/Board Member |
Estadísticas
Internacional
Francia | 25 |
Estados Unidos | 15 |
Bélgica | 7 |
Rusia | 3 |
Reino Unido | 3 |
Sectorial
Health Technology | 27 |
Consumer Services | 11 |
Finance | 7 |
Commercial Services | 3 |
Producer Manufacturing | 2 |
Operativa
Director/Board Member | 36 |
Corporate Officer/Principal | 9 |
Private Equity Investor | 7 |
Masters Business Admin | 6 |
Chief Tech/Sci/R&D Officer | 5 |
Las relaciones más conectadas
Insiders | |
---|---|
Ekaterina Smirnyagina | 21 |
Thierry Laugel | 18 |
Jérôme Féraud | 12 |
Stanislav Glezer | 8 |
Rémi Soula | 6 |
Stephen Daly | 5 |
Martin Gaudier | 2 |
- Bolsa de valores
- Insiders
- Savita Bernal
- Conexiones Empresas